Table 1.
General characteristic of the study subjects for validation study.
| SALS | PD | HCs | |
|---|---|---|---|
| Cases, n | 83 | 24 | 61 |
| Sex, female (%) | 37 (44.58%) | 10 (41.66%) | 27 (44.26%) |
| Mean age (mean ± SD, years) | 55.92 ± 7.38 | 58.51 ± 5.60 | 54.20 ± 12.78 |
| Mean onset age (mean ± SD, years) | 54.49 ± 6.35 | 56.67 ± 4.87 | − |
| Disease duration* (mean ± SD, months) | 17.33 ± 13.68 | 28.92 ± 12.84 | − |
| Mean ALSFRS-R | 38.50 ± 6.22 | − | − |
| INITIAL SYMPTOMS | |||
| Bulbar | 16 | − | − |
| Upper limb | 47 | − | − |
| Lower limb | 20 | − | − |
| ONSET AGE | |||
| ≤40 years | 12 | − | − |
| >40 years | 71 | − | − |
| Disease duration# (mean ± SD, months) | 28.44 ± 15.96 | − | − |
*
Mean disease duration from onset to collection in all SALS patients.
#
Mean disease duration from onset to death in 58 SALS.